ADIAL PHARMACEUTICALS, INC. — Major Shareholding Notification 2021

Aug 13, 2021

SC 13G 1 sc13g.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. __)

| Adial
Pharmaceuticals, Inc. |
| --- |
| (Name
of Issuer) |
| Common
Stock, par value $0.001 per share |
| (Title
of Class of Securities) |
| 00688A106 |
| (CUSIP
Number) |
| August
3, 2021 |
| (Date
of Event Which Requires Filing of This Statement) |

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

| [ ] | Rule
13d-1(b) |
| --- | --- |
| [X] | Rule
13d-1(c) |
| [ ] | Rule
13d-1(d) |

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CUSIP No. 00688A106

| 1 | NAME
OF REPORTING PERSONS S.S.
OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Mark
Howard Peikin |
| --- | --- |
| 2 | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)
[ ] (b)
[ ] |
| 3 | SEC
USE ONLY |
| 4 | CITIZENSHIP
OR PLACE OF ORGANIZATION United
States |

| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE
VOTING POWER 1,120,241 (1) |
| --- | --- |
| 6 | SHARED
VOTING POWER 0 |
| 7 | SOLE
DISPOSITIVE POWER 1,120,241 (1) |
| 8 | SHARED
DISPOSITIVE POWER 0 |

| 9 | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,120,241 (1) |
| --- | --- |
| 10 | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) |
| 11 | PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.52%
(Based upon 20,298,156 outstanding shares of common stock as of August 12, 2021) |
| 12 | TYPE
OF REPORTING PERSON* IN |

Field: Page; Sequence: 2

Field: /Page

CUSIP No. 00688A106

Item 1(a). Name of Issuer:

Adial Pharmaceuticals, Inc. (the “Issuer”).

Item 1(b). Address of Issuer’s Principal Executive Offices:

1180 Seminole Trail, Suite 495

Charlottesville, Virginia 29902

United States of America

Item 2(a). Name of Person Filing.

Mark Howard Peikin.

Item 2(b). Address of Principal Business Office or, if None, Residence.

1875 N.W. Corporate Blvd., Ste 290, Boca Raton, FL 33431.

Item 2(c). Citizenship.

United States.

Item 2(d). Title of Class of Securities.

Common stock, par value $0.001 per share.

Item 2(e). CUSIP Number.

00688A106

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

Item 4. Ownership.

(a)	Amount beneficially owned: 1,120,241 (1)
(b)	Percent of class: 5.52%
(c)	Number of shares as to which the Reporting Person has:

(i)	Sole power to vote or to direct the vote: 1,120,241 (1)
(ii)	Shared power to vote or to direct the vote: 0
(iii)	Sole power to dispose or to direct the disposition of: 1,120,241 (1)
(iv)	Shared power to dispose or to direct the disposition of: 0

(1) Mark Howard Peikin is the beneficial owner of Bespoke Growth Partners, Inc. and has the power to vote and dispose of the shares of the Issuer held by Bespoke Growth Partners, Inc.

Item 5. Ownership of Five Percent or Less of a Class.

Not applicable.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company.

Not applicable.

Item 8. Identification and Classification of Members of the Group.

Not applicable.

Item 9. Notice of Dissolution of Group.

Not applicable.

Item 10. Certifications.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Field: Page; Sequence: 3

Field: /Page

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: August 13, 2021
Mark Howard Peikin

Field: Page; Sequence: 4; Options: Last

Field: /Page